Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SINOGENE
company
About
SINOGENE creates an animal gene editing and somatic cell cloning technology platform.
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥20M
- Industries
- Biotechnology,Genetics,Health Care,Pet
- Founded date
- Nov 14, 2012
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥80M
SINOGENE has raised a total of
¥80M
in funding over 2 rounds. Their latest funding was raised on
Jun 23, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 23, 2020 | Series B | ¥20M | 2 |
|
— | Detail |
| Sep 1, 2018 | Series Unknown | ¥50M | 1 | — | — | Detail |
| Mar 21, 2018 | Series A | ¥10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
4
SINOGENE is funded by 4 investors.
Shunqi Touzi
and Xinuo Hengtong
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
|
|
— | Series B |
|
|
— | Series Unknown |
Lotus Lake Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
